| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 河北常山生化药业股份有限公司是国内少数拥有完整肝素产品产业链、能够同时从事肝素钠原料药和肝素制剂药品研发、生产和销售的龙头企业之一.公司主导产品包括肝素钠原料药(注射级和非注射级)、低分子量肝素钙注射液和肝素钠注射液,为国内多家标准肝素制剂生产企业提供精制肝素原料药,是国内最大的标准肝素制剂生产企业--天津生化的独家肝素原料药供应商.和国内的主要竞争对手相比,发行人精制肝素原料药的出口额占自身销售额的60%左右,出口依赖程度较低,在国内肝素原料药市场的市场份额居第一位.以2010 年1-9 月我国主要肝素类产品生产企业的出口金额计算,常山药业的出口规模居全国第六位。 | ||||||||||||||||||||||||
| Main Business | 研发、生产和销售治疗心脑血管疾病药物 | ||||||||||||||||||||||||
| Legal Representative | 高晓东 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 刘中英 | ||||||||||||||||||||||||
| Solicitors | 北京国枫律师事务所 | ||||||||||||||||||||||||
| Auditors | 中喜会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0311-89190181 | ||||||||||||||||||||||||
| Fax No | 0311-89190182 | ||||||||||||||||||||||||
| Website | www.hbcsbio.com | ||||||||||||||||||||||||
| comcsshf910@qq.com;csyyzqb@163.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/08/2011 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -1.350 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 1.971 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 21.231B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |